BNT162b2 COVID-19 vaccination uptake, safety, effectiveness and waning in children and young people aged 12–17 years in Scotland

BNT162b2 COVID-19 vaccination uptake, safety, effectiveness and waning in children and young people aged 12–17 years in Scotland

Summary: Background: The two-dose BNT162b2 (Pfizer-BioNTech) vaccine has demonstrated high efficacy against COVID-19 disease in clinical trials of children and young people (CYP). Consequently, we investigated the uptake, safety, effectiveness and waning of the protective effect of the BNT162b2 aga...

Full description

Bibliographic Details
Main Authors: Igor Rudan, Tristan Millington, Karen Antal, Zoe Grange, Lynda Fenton, Christopher Sullivan, Audrey Buelo, Rachael Wood, Lana Woolford, Olivia V. Swann, Josephine L.K. Murray, Lucy A. Cullen, Emily Moore, Fasih Haider, Fatima Almaghrabi, Jim McMenamin, Utkarsh Agrawal, Syed Ahmar Shah, Steven Kerr, Colin R. Simpson, Srinivasa Vittal Katikireddi, Sir Lewis D. Ritchie, Chris Robertson, Sir Aziz Sheikh
Format: Article
Language:English
Published: Elsevier 2022-12-01
Series:The Lancet Regional Health. Europe
Subjects:
COVID-19
BNT162b2 COVID-19 vaccination
Vaccine uptake
Vaccine safety
Vaccine effectiveness
Vaccine waning
Online Access:http://www.sciencedirect.com/science/article/pii/S2666776222002095

Internet

http://www.sciencedirect.com/science/article/pii/S2666776222002095

Similar Items